As the global economy mends, the 2021 growth of Piracetam will have significant change from previous year. According to our (LP Information) latest study, the global Piracetam market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Piracetam market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Piracetam market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Piracetam market, reaching US$ million by the year 2028. As for the Europe Piracetam landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Piracetam players cover Jiangsu Chenpai Pharmaceutical Group, Shandong Weigao Pharmaceutical, Shandong Xinhua Pharmaceutical, and Guorui Pharmaceutical Group, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Piracetam market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Injection
Capsule
Tablets
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Cerebrovascular Disease
Traumatic Brain Injuries
Toxic Encephalopathy
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Jiangsu Chenpai Pharmaceutical Group
Shandong Weigao Pharmaceutical
Shandong Xinhua Pharmaceutical
Guorui Pharmaceutical Group
Shanghai Modern Hazen Shangqiu Pharmaceutical
Duoduo Pharmaceutical
Shandong Fangming Pharmaceutical Group
Hangzhou Minsheng Pharmaceutical
Shandong Qidu Pharmaceutical
Guangdong Litai Pharmaceutical
Chenxin Pharmaceutical
Ruiyang Pharmaceutical
Hainan Huanglong Pharmaceutical
Hainan Tongyong Kangli Pharmaceutical
China Resources Shuanghelimin Pharmaceutical Jinan
Tianjin Jinyao group Henan Lixin Pharmaceutical
Zhejiang Ruixin Pharmaceutical
Furen Pharmaceutical Group
Jiangsu Yabangshengyuan Pharmaceutical
Shandong Xinyi Pharmaceutical
Shanghai Shangyao Xinyi Pharmaceutical
Shanghai Huayuan Anhui Renji Pharmaceutical
Shanghai Pukang Pharmaceutical
Northeast Pharmaceutical Group Renhetang Pharmaceutical
Huazhong Pharmaceutical
Nanjing baijingyu Pharmaceutical
Hefei Jiulian Pharmaceutical
Yichang Renfu Pharmaceutical
Guangdong Sancai Shiqi District Pharmaceutical
Guangdong South Ch
Guangdong Bangmin Pharmaceutical
Kaifeng Pharmaceutical Group
Jiangsu Shenhua Pharmaceutical
Jiangsu Pengyao Pharmaceutical
Hunan Dinuo Pharmaceutical
Shijiazhuang No. 4 Pharmaceutical
Chengdu Tongde Pharmaceutical
Shanxi Bailu Pharmaceutical
Jiangxi Qingchun Kangyuan Pharmaceutical
Liaoning Tianlong Pharmaceutical
Liaoyuan Yulong Yadong Pharmaceutical
Changchun Changqing Pharmaceutical Group